Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: Results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2733-2738

  Rosen, Harald R ^a   Jatzko, Gerhard ^b   Repse, Stane ^b   Potrc, Stojan ^b   Neudorfer, Herbert ^b   Sandbichler, Peter ^b   Zacherl, Johannes ^b   Rabl, Hans ^b   Holzberger, Peter ^b   Lisborg, Peter ^b   Czeijka, Martin ^b  

^a DANUBE HOSPITAL   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; MITOMYCIN;

ABDOMINAL WALL CLOSURE; ADULT; AGED; ARTICLE; AUSTRIA; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER RECURRENCE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SLOVENIA; STOMACH CANCER;

EID: 0031926748     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2733     Document Type: Article

References (28)

1. Longmire WP Jr: A current view of gastric cancer in the US. Ann Surg 218:579-582, 1993
2. Cady B, Ricardo L, Silverman ML, et al: Gastric adenocarcinoma. A disease in transition. Arch Surg 124:303-308, 1989
3. McNeer G, Vanderberg H, Donn F: A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 134:1-7, 1951
4. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: Areas of failure in a reoperation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982
5. Dupont JB Jr, Lee JR, Burton GR, et al: Adenocarcinoma of the stomach: Review of 1,497 cases. Cancer 41:941-947, 1978
6. Sugarbaker PH, Cunliffe WJ, Belliveau J: Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16:83-97, 1989
7. Hagiwara A, Takahashi T, Lee R, et al: Enhanced chemotherapeutic efficacy on carcinomatous peritonitis using a new dosage form in animal experiments. Anticancer Res 7:167-170, 1987
8. Hagiwara A, Takahashi T, Kojima O, et al: Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339:629-631, 1992
9. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma: An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-43, 1965
10. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11:127-139, 1981
11. Czejka M, Jäger W, Schüller J: Mitomycin C determination using loop-column extraction: A rapid and sensitive high-performance liquid chromatographic assay for pharmacokinetic studies with Spherex starch particles. J Chromatogr 497:336-341, 1989
12. Lesser MR: Design and implementation of clinical trials, in Mike V, Stanley KE (eds): Statistics in Medical Research. New York, NY, Wiley, 1981, pp 238-242
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Amer Stat Assoc 53:457-481, 1958
14. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
15. Lee ET: Statistical Methods for Survival Data Analysis. New York, NY, Wiley, 1992
16. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc B 34:187-220, 1972
17. Fleiss JL: Statistical Methods for Rates and Proportions. New York, NY, Wiley, 1981
18. Sachs L: Angewandte Statistik. Anwendungen Statistischer Methoden. Berlin, Germany, Springer, 1997
19. Roder JD, Böttcher K, Siewert JR, et al: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089-2097, 1993
20. Archer S, Gray B: Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastasis. Surgery 108:502-507, 1990
21. Sautner T, Hofbauer F, Depisch D, et al: Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 12:970-974, 1994
22. Schiessel R, Funovics J, Schick B, et al: Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: Results of a randomised trial. Acta Med Aust 16:68-69, 1989
23. Takahashi T, Hagiwara A: Treatment of lymph node metastasis and peritoneal disseminated metastasis by anticancer agents absorbed on activated carbon. Asian Med J 32:175-178, 1989
24. Hagiwara A, Takahashi T, Ueda T, et al: Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits. Surgery 104:871-881, 1988
25. Bozzetti F, Marubini E: Carbon-adsorbed mitomycin prophylaxis against recurrence of gastric cancer. Lancet 339:1608, 1992
26. Schlemper RJ, Itabashi M, Kato Y, et al: Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 349:1725-1729, 1997
27. Crookes P, Leichmann CG, Leichman L, et al: Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy. Cancer 79:1767-1775, 1997
28. Kelsen DP: Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 23:379-389, 1996